{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:22:17Z","timestamp":1791235337279,"version":"4.1.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T00:00:00Z","timestamp":1552521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0212614","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T17:31:34Z","timestamp":1552584694000},"page":"e0212614","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":77,"title":["Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction"],"prefix":"10.1371","volume":"14","author":[{"given":"S\u00e9bastien","family":"Miranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5632-7713","authenticated-orcid":true,"given":"Paul","family":"Billoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Damian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Alain","family":"Thiebaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Schapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maelle","family":"Le Besnerais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Jouen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Galas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Le Cam-Duchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robinson","family":"Joannides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ygal","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,3,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"S Miyakis","year":"2006","journal-title":"J Thromb Haemost JTH"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/art.21549","article-title":"Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB\/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1\/ERK pathway","volume":"54","author":"C L\u00f3pez-Pedrera","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1177\/0961203308096662","article-title":"Tissue factor in the antiphospholipid syndrome","volume":"17","author":"AV Kinev","year":"2008","journal-title":"Lupus"},{"key":"ref4","first-page":"503","article-title":"IL-2, IL-6 and TNF levels in primary antiphospholipid syndrome","volume":"10","author":"K Ahmed","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/01.RES.88.2.245","article-title":"Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin","volume":"88","author":"SS Pierangeli","year":"2001","journal-title":"Circ Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/1529-0131(200001)43:1<55::AID-ANR8>3.0.CO;2-M","article-title":"Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis","volume":"43","author":"G Kaplanski","year":"2000","journal-title":"Arthritis Rheum"},{"key":"ref7","article-title":"Role of toll-like receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome","author":"Y Benhamou","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jama.2009.1346","article-title":"Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome","volume":"302","author":"M Charakida","year":"2009","journal-title":"JAMA J Am Med Assoc"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1742-1241.2004.00162.x","article-title":"Impaired brachial endothelial function in patients with primary anti-phospholipid syndrome","volume":"58","author":"F Mercanoglu","year":"2004","journal-title":"Int J Clin Pract"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nbd.2007.12.004","article-title":"Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome","volume":"30","author":"D Tanne","year":"2008","journal-title":"Neurobiol Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.vph.2015.03.014","article-title":"Infliximab improves endothelial dysfunction in a mouse model of antiphospholipid syndrome: role of reduced oxidative stress","volume":"71","author":"Y Benhamou","year":"2015","journal-title":"Vascul Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/jth.12363","article-title":"Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients","volume":"11","author":"A Schmidt-Tanguy","year":"2013","journal-title":"J Thromb Haemost JTH"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-0037-1613033","article-title":"Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies","volume":"87","author":"RG Espinola","year":"2002","journal-title":"Thromb Haemost"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2009-04-213520","article-title":"Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug","volume":"115","author":"JH Rand","year":"2010","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/rheumatology\/kex378","article-title":"The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies","volume":"57","author":"K Schreiber","year":"2018","journal-title":"Rheumatol Oxf Engl"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.thromres.2018.07.021","article-title":"Development of a thrombin generation test in cultured endothelial cells: Evaluation of the prothrombotic effects of antiphospholipid antibodies","volume":"169","author":"P Billoir","year":"2018","journal-title":"Thromb Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1172\/JCI39828","article-title":"Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via \u03b22GPI and apoER2","volume":"121","author":"S Ramesh","year":"2011","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.ATV.16.11.1319","article-title":"Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s","volume":"16","author":"JC Reverter","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/art.1780400509","article-title":"Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression","volume":"40","author":"MJ Cuadrado","year":"1997","journal-title":"Arthritis Rheum"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1055\/s-0037-1614881","article-title":"Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome","volume":"82","author":"PM Dobado-Berrios","year":"1999","journal-title":"Thromb Haemost"},{"key":"ref21","first-page":"1328","article-title":"Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies","volume":"153","author":"A Kornberg","year":"1994","journal-title":"J Immunol Baltim Md 1950"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-0037-1614977","article-title":"The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome","volume":"79","author":"O Amengual","year":"1998","journal-title":"Thromb Haemost"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/1529-0131(199808)41:8<1420::AID-ART11>3.0.CO;2-U","article-title":"Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes","volume":"41","author":"JC Reverter","year":"1998","journal-title":"Arthritis Rheum"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1182\/blood-2004-01-0145","article-title":"Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep","volume":"104","author":"H Zhou","year":"2004","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/01.CIR.99.15.1997","article-title":"Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo","volume":"99","author":"SS Pierangeli","year":"1999","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1160\/TH12-06-0421","article-title":"Endosomal NADPH-oxidase is critical for induction of the tissue factor gene in monocytes and endothelial cells. Lessons from the antiphospholipid syndrome","volume":"109","author":"N Prinz","year":"2013","journal-title":"Thromb Haemost"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1160\/TH06-07-0408","article-title":"Thrombin generation, a function test of the haemostatic-thrombotic system","volume":"96","author":"HC Hemker","year":"2006","journal-title":"Thromb Haemost"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-2141.2008.07267.x","article-title":"Thrombin generation testing in routine clinical practice: are we there yet?","volume":"142","author":"JJ Van Veen","year":"2008","journal-title":"Br J Haematol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1538-7836.2011.04212.x","article-title":"Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activity","volume":"9","author":"I Dienava-Verdoold","year":"2011","journal-title":"J Thromb Haemost JTH"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0037-1613433","article-title":"Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants","volume":"89","author":"V Regnault","year":"2003","journal-title":"Thromb Haemost"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.thromres.2015.03.030","article-title":"Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndrome","volume":"135","author":"M Efthymiou","year":"2015","journal-title":"Thromb Res"},{"key":"ref32","first-page":"31","article-title":"Prothrombotic Effect of Anti-beta-2 Glycoprotein-1 Antibodies on the Expression of Tissue Factor, Thrombomodulin, and Plasminogen Activator Inhibitor-1 in Endothelial Cells","volume":"47","author":"null Rikarni","year":"2015","journal-title":"Acta Medica Indones"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1161\/01.CIR.96.12.4380","article-title":"Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice","volume":"96","author":"MH Edwards","year":"1997","journal-title":"Circulation"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1016\/S2352-3026(16)30079-5","article-title":"Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2\/3, non-inferiority trial","volume":"3","author":"H Cohen","year":"2016","journal-title":"Lancet Haematol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1182\/blood-2017-11-814681","article-title":"Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium","volume":"131","author":"A Sacharidou","year":"2018","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.intimp.2018.08.008","article-title":"Attenuation of antimalarial agent hydroxychloroquine on TNF-\u03b1-induced endothelial inflammation","volume":"63","author":"R Li","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/annrheumdis-2016-210012","article-title":"Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase","volume":"76","author":"N M\u00fcller-Calleja","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1111\/jth.13865","article-title":"Antiphospholipid antibody-induced cellular responses depend on epitope specificity: implications for treatment of antiphospholipid syndrome","volume":"15","author":"N M\u00fcller\u2010Calleja","journal-title":"J Thromb Haemost"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0212614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T20:41:34Z","timestamp":1663101694000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0212614"}},"subtitle":[],"editor":[{"given":"Michael","family":"Bader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,14]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0212614","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,14]]}}}